P2X7 as a potential therapeutic target has been investigated in numerous diseases such as chronic inflammatory diseases, neurodegenerative pathologies associated with inflammation, cancer and mental disorders (reviewed in Di Virgilio et al., 2017; Savio et al., 2018; Young and Gorecki, 2018). This evidence concerns the gene P2RX7 and psychiatric disorder.